Results 221 to 230 of about 2,950,586 (348)

Comprehensive safety evaluation of <i>Withania somnifera</i> (Ashwagandha): an AI-driven meta-analysis and quantitative structure-activity relationship based toxicity assessment. [PDF]

Front Nutr
Ronen Y, Ebert C, Tamim-Yecheskel BC, Zev S, Kantor O, Arbel HB.   +5 more
europepmc   +1 more source

The Toxic Mix of Multiculturalism and Medicine: The Credentialing and Professional-Entry Experience for Persons of African Descent [PDF]

Lorne Foster
openalex   +1 more source

Characterization of Clinical Phenotype to Glial Fibrillary Acidic Protein Concentrations in Alexander Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine the concentration of glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and plasma in Alexander disease (AxD) and whether GFAP levels are predictive of disease phenotypes. Methods CSF and plasma were collected (longitudinally when available) from AxD participants and non‐AxD controls.
Amy T. Waldman, Asako Takanohashi, Joshua Y. Joung, Geraldine W. Liu, Kaley Arnold, Amy Pizzino, Walter Faig, Sarah Woidill, Sona Narula, Adeline L. Vanderver   +9 more
wiley   +1 more source

Comprehensive review on environmental pollution caused by 6PPD-quinone and remediation strategies. [PDF]

RSC Adv
Sivalingam S, Gayathri J, Boopathy G, Choi D, Sangeetha Selvan K.   +4 more
europepmc   +1 more source

Diffusion Spectrum Imaging Maps Early Axonal Loss and a Unique Progressive Signal in Neuronal Intranuclear Inclusion Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To delineate specific in vivo white matter pathology in neuronal intranuclear inclusion disease (NIID) using diffusion spectrum imaging (DSI) and define its clinical relevance. Methods DSI was performed on 42 NIID patients and 38 matched controls.
Kaiyan Jiang, Yixiu Pei, Xiaobao Hu, Ying Xiong, Fang Wang, Yanyan Yu, Min Zhu, Dandan Tan, Meihong Zhou, Daojun Hong, Fuqing Zhou   +10 more
wiley   +1 more source

Erratum to “Peroxisome Proliferator-Activated Receptors Alpha, Beta, and Gamma mRNA and Protein Expression in Human Fetal Tissues”

PPAR Research, 2010
Barbara D. Abbott, Carmen R. Wood, Andrew M. Watkins, Kaberi P. Das, Christopher S. Lau   +4 more
doaj   +1 more source

OATP2B1 Deficiency Ameliorates Irinotecan-Induced Gastrointestinal Toxicity. [PDF]

Clin Transl Sci
Taheri H, de Bruijn P, Li Y, Kleinert NR, Corps KN, Mathijssen RHJ, Huang KM, Sparreboom A, Hu S.   +8 more
europepmc   +1 more source

Reduction in Renal Relapse and Preservation of Long‐Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond Y. H. Yap, Ka Lai Lee, Philip H. Li, Iris Y. K. Tang, Chak Sing Lau, Shirley C. W. Chan   +6 more
wiley   +1 more source

Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study.

JMIR Cancer
Amaeshi L, Laufer L, Fedorov K, Sisto A, Levitz D, Mathew R, Wright K, Cooper D, Goldfinger M, Mantzaris I, Sica RA, Gritsman K, Konopleva M, Gupta R, Kornblum N, Zhang C, Kim M, Verma A, Rapkin B, Shastri A, Shah N.   +20 more
europepmc   +1 more source

Two-fraction Ultrahypofractionated Radiotherapy with focal BOost for intermediate-risk, localized prostate cancer (TURBO): study protocol of a phase II, randomized controlled clinical trial. [PDF]

Trials
Lalmahomed TA, Monninkhof EM, van Rijssel MJ, van Melick HHE, Verkooijen HM, de Boer JCJ, van der Voort van Zyp JRN.   +6 more
europepmc   +1 more source